Related Experiment Video

Updated: Apr 27, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K

MicroRNA-451 regulates activating transcription factor 2 expression and inhibits liver cancer cell migration

Guixiang Lv1, Zheng Hu1, Yi Tie1

  • 1Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.

Oncology Reports
|June 28, 2014
PubMed

Insights

MicroRNA-451 (miR-451) acts as a tumor suppressor in liver cancer by downregulating activating transcription factor 2 (ATF2). This study reveals miR-451 inhibits hepatocellular carcinoma cell migration, offering new diagnostic and therapeutic insights.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) exhibit context-dependent roles as oncogenes or tumor suppressors.
  • Understanding specific miRNA functions is crucial for cancer diagnosis and treatment.

Purpose of the Study:

  • To investigate the role of miR-451 in hepatocellular carcinoma (HCC).
  • To identify molecular targets and mechanisms underlying miR-451's function in HCC.

Main Methods:

  • Quantitative analysis of miR-451 expression in HCC tissues.
  • In vitro functional assays (cell migration) using hepatoma cell lines.
  • Identification of miR-451 targets via 3'UTR binding analysis.
  • In vivo correlation studies and immunohistochemistry for ATF2 localization.

Main Results:

  • miR-451 was significantly downregulated in HCC tissues.
  • miR-451 suppressed the migration of HepG2 and SK-Hep-1 cells.
  • Activating transcription factor 2 (ATF2) was identified as a direct target of miR-451.
  • ATF2 showed increased nuclear localization in HCC tissues, correlating inversely with miR-451 levels.

Conclusions:

  • miR-451 functions as a tumor suppressor in HCC by inhibiting cell migration.
  • The miR-451/ATF2 axis represents a novel mechanism in liver cancer progression.
  • Targeting miR-451 or ATF2 may offer therapeutic strategies for HCC.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
MicroRNAs01:22

MicroRNAs

9.8K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K